Monday, September 11, 2017

Teva Names Kare Schultz as New Chief Executive

Teva Pharmaceutical Industries named Kare Schultz as its new chief executive, ending months of speculation over who will lead the Israeli drug company.

from WSJ.com: US Business http://ift.tt/2jhqmAy
via IFTTT

No comments:

Post a Comment